| Q59850174 | Action of melatonin in primary culture of canine mammary tumors |
| Q91740725 | Activation of Interleukin-1 Beta in Arterialized Vein Grafts and the Influence of the -511C/T IL-1β Gene Polymorphism |
| Q45000178 | Apoptosis, cell proliferation and modulation of cyclin-dependent kinase inhibitor p21(cip1) in vascular remodelling during vein arterialization in the rat. |
| Q47239487 | Arachidonic Acid Metabolite as a Novel Therapeutic Target in Breast Cancer Metastasis |
| Q58718136 | CXCR2-Expressing Tumor Cells Drive Vascular Mimicry in Antiangiogenic Therapy-Resistant Glioblastoma |
| Q42645448 | Canonical NFκB signaling in myeloid cells is required for the glioblastoma growth |
| Q36684023 | Combination of vatalanib and a 20-HETE synthesis inhibitor results in decreased tumor growth in an animal model of human glioma |
| Q60932001 | Corrigendum to "CXCR2-Expressing Tumor Cells Drive Vascular Mimicry in Antiangiogenic Therapy-Resistant Glioblastoma" Neoplasia, October 2018, Volume 20, Issue 10, Pages 1070-1082 |
| Q34768493 | Differential biodistribution of intravenously administered endothelial progenitor and cytotoxic T-cells in rat bearing orthotopic human glioma. |
| Q92382975 | Differential in vivo biodistribution of 131I-labeled exosomes from diverse cellular origins and its implication for theranostic application |
| Q38872998 | Effect of Curcumin on Pro-angiogenic Factors in the Xenograft Model of Breast Cancer. |
| Q37458674 | Effect of melatonin on tumor growth and angiogenesis in xenograft model of breast cancer |
| Q37474359 | Effects of tyrosine kinase inhibitors and CXCR4 antagonist on tumor growth and angiogenesis in rat glioma model: MRI and protein analysis study. |
| Q38700026 | Efficacy of melatonin, IL-25 and siIL-17B in tumorigenesis-associated properties of breast cancer cell lines |
| Q90659233 | Evaluation of Angiogenesis Process after Metformin and LY294002 Treatment in Mammary Tumor |
| Q55645543 | Evaluation of interleukins 8 and 12, CA 15-3 and free circulating DNA as prognostic markers in dogs with mammary tumors. |
| Q47149921 | Evaluation of the anti-angiogenic action of melatonin in breast cancer. |
| Q49181569 | Evaluation of the expression of angiogenic factors in breast cancer after curcumin treatment. |
| Q33793046 | HET0016 decreases lung metastasis from breast cancer in immune-competent mouse model |
| Q21131825 | HET0016, a selective inhibitor of 20-HETE synthesis, decreases pro-angiogenic factors and inhibits growth of triple negative breast cancer in mice |
| Q33377194 | Human saphenous vein organ culture under controlled hemodynamic conditions |
| Q46058222 | Induction of CRP3/MLP expression during vein arterialization is dependent on stretch rather than shear stress |
| Q38721748 | Inhibition of Epithelial-Mesenchymal Transition and Metastasis by Combined TGFbeta Knockdown and Metformin Treatment in a Canine Mammary Cancer Xenograft Model. |
| Q38723308 | Inhibition of Epithelial-mesenchymal Transition in Response to Treatment with Metformin and Y27632 in Breast Cancer Cell Lines |
| Q37615383 | Intravenous Formulation of HET0016 Decreased Human Glioblastoma Growth and Implicated Survival Benefit in Rat Xenograft Models |
| Q47773621 | Major Challenges and Potential Microenvironment-Targeted Therapies in Glioblastoma. |
| Q51632261 | Melatonin Regulates Angiogenic Factors under Hypoxia in Breast Cancer Cell Lines. |
| Q38776358 | Melatonin Regulates Angiogenic and Inflammatory Proteins in MDA-MB-231 Cell Line and in Co-culture with Cancer-associated Fibroblasts. |
| Q51092841 | Melatonin and IL-25 modulate apoptosis and angiogenesis mediators in metastatic (CF-41) and non-metastatic (CMT-U229) canine mammary tumour cells. |
| Q37200722 | Melatonin decreases breast cancer metastasis by modulating Rho-associated kinase protein-1 expression. |
| Q55195075 | P62. Effectiveness of melatonin, IL-25 and siRNA IL-17B in growth control of breast cancer cell lines. |
| Q51043750 | Prognostic value of vascular endothelial growth factor and hypoxia-inducible factor 1α in canine malignant mammary tumors. |
| Q45892427 | Serum and molecular assessment of vascular endothelial growth factor (VEGF) and hypoxia-inducible factor 1α (HIF-1α) in canine mammary tumors |
| Q91922308 | Therapeutic Potential of Melatonin in the Regulation of MiR-148a-3p and Angiogenic Factors in Breast Cancer |
| Q33868524 | Vascular Mimicry: A Novel Neovascularization Mechanism Driving Anti-Angiogenic Therapy (AAT) Resistance in Glioblastoma |
| Q41096029 | Vascular mimicry in glioblastoma following anti-angiogenic and anti-20-HETE therapies. |